Cork MJ, Lockshin B, Pinter A, Chen Z, Shumel B, Prescilla R. Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial. Acta Derm Venereol [Internet]. 2024 Feb. 12 [cited 2024 Aug. 24];104:adv13467. Available from: https://medicaljournalssweden.se/actadv/article/view/13467